Home Newsfeeds Atossa Genetics Q3 EPS $(0.06) Down From $(0.04) YoY

Atossa Genetics Q3 EPS $(0.06) Down From $(0.04) YoY

Atossa Genetics (NASDAQ:ATOS) reported quarterly losses of $(0.06) per share. This is a 50 percent decrease over losses of $(0.04) per share from the same period last year.

byBenzinga Newsdesk

November 7, 2022

1 minute read

Atossa Genetics (NASDAQ:ATOS) reported quarterly losses of $(0.06) per share. This is a 50 percent decrease over losses of $(0.04) per share from the same period last year.

Watching ACADIA Pharmaceuticals; Traders Circulate “ACADIA Pharmaceuticals Wins Summary Judgement In A Patent Suit Regarding Its Drug Nuplazid, Which Is Used To Treat Parkinson’s Disease, Against Generic Maker MSN Laboratories”; Shares Now Up 27%

By Benzinga Newsdesk

December 13, 11:25 AM

Acadia Pharmaceuticals stock surges 32% after win in patent suit over Nuplazid | Seeking Alpha

ACAD

Greif, Inc. Declares Increased Quarterly Dividend From $0.50 To $0.52/Share

By Happy Mohamed

August 29, 10:08 AM

Greif, Inc. (NYSE:GEF, GEF.B)))), a global leader in industrial packaging products and services, announced today that its Board of Directors has declared quarterly cash dividends of $0.52 per share on its

GEF

Earnings

Looking Into Graco’s Return On Capital Employed

By Benzinga Insights

July 29, 9:57 AM

According to Benzinga Pro, during Q2, Graco (NYSE:GGG) earned $117.38 million, a 16.4% increase from the preceding quarter. Graco also posted a total of $548.55 million in sales, a 10.98% increase since Q1.

GGG